EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

 26.45p
   
  • Change Today:
      0.000p
  • 52 Week High: 31.85
  • 52 Week Low: 18.75
  • Currency: UK Pounds
  • Shares Issued: 449.09m
  • Volume: 6,647
  • Market Cap: £118.79m
  • Beta: 0.01

EKF Overview

EKF Diagnostics is a global medical manufacturer of point-of-care and central lab devices and chemistry reagents including hemoglobin tests, HbA1c tests, glucose and lactate tests.
Competitors: Physiomics, SDI Group , Polarean Imaging
Registrars: Capita Registrars

Key Personnel

CEO: Gavin T Jones
CFO: Stephen (Steve) Young
Executive Chairman: Julian Baines
Senior Independent Director: Christian Alexander Rigg
Non-Executive Dir: Jenny Winter, Christopher H B Mills

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 20 710570
Fax: +44 (0)29 20 705715
Website: http://www.ekfdiagnostics.com

Listings

Sector: Financials(LSE)
Index: FTSE AIM All-Share
ISIN: GB0031509804

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 26.45p
Change Today 0.000p
% Change 0.00 %
52 Week High 31.85
52 Week Low 18.75
Volume 6,647
Shares Issued 449.09m
Market Cap £118.79m
Beta 0.01

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
82% below the sector average82% below the sector average82% below the sector average82% below the sector average82% below the sector average
Price Trend
0.94% below the market average0.94% below the market average0.94% below the market average0.94% below the market average0.94% below the market average
8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average
Income Not Available
Growth
58.24% above the market average58.24% above the market average58.24% above the market average58.24% above the market average58.24% above the market average
56.04% above the sector average56.04% above the sector average56.04% above the sector average56.04% above the sector average56.04% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 06-Jun-2025

Time Volume / Share Price
09:05 5,000 @ 26.00p
08:40 1,000 @ 26.00p
08:00 628 @ 26.00p
08:00 19 @ 25.80p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page